Verify any claim · lenz.io
Claim analyzed
Science“Skeletal muscle lacks glucose-6-phosphatase and therefore stores glycogen for internal use rather than releasing glucose into the bloodstream.”
The conclusion
This claim accurately reflects a well-established biochemical principle. Multiple authoritative biomedical sources confirm that skeletal muscle lacks functional glucose-6-phosphatase and therefore cannot convert glucose-6-phosphate to free glucose for export into the bloodstream, meaning muscle glycogen serves as a local energy reserve. The only minor caveat is that the causal "therefore" slightly oversimplifies: muscle glycogen retention also reflects other physiological factors, and some sources describe G6Pase distribution as "mainly" liver/kidney rather than stating absolute absence.
Based on 10 sources: 8 supporting, 0 refuting, 2 neutral.
Caveats
- One primary source (PMC-NIH) describes G6Pase as found 'mainly' in liver and kidney, which is slightly less absolute than the claim's 'lacks' framing, though other authoritative sources use unambiguous 'absence' language for skeletal muscle.
- The claim's single-cause 'therefore' framing is somewhat reductive; muscle glycogen retention also reflects muscle's high local ATP demand and other regulatory factors beyond just the absence of one enzyme.
- Muscle glycogen-derived glucose-6-phosphate can enter pathways other than glycolysis (e.g., pentose phosphate pathway), though it still cannot be exported as free glucose — the claim's 'internal use' phrasing is correct but could be more precise.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
The use of muscle glycogen during exercise reduces glucose uptake from the blood, thereby helping to maintain blood glucose in the absence of exogenous carbohydrates. That ATP is produced by the oxidation of fatty acids from the bloodstream and from intramuscular triglyceride stores, along with glucose supplied by the bloodstream and intramuscular glycogen stores.
Glucose-6-phosphatase (G6Pase), an enzyme found mainly in the liver and the kidneys, plays the important role of providing glucose during starvation.
Muscle glycogen serves mainly as a source of metabolic fuel for your muscles... If your muscles relied on glucose from your bloodstream for this energy, your body would quickly run out of glucose. Because of this, your body stores three-quarters of your total glycogen in all of your skeletal muscles so they have a consistent supply of energy... without dramatically affecting the levels of your blood glucose.
glucose-6 phosphatase (G6Pase), which is expressed only in the liver, kidneys, and intestine.
Elevated blood glucose concentrations result in increased intracellular levels of glucose 6-phosphate in liver, skeletal muscle, and adipose tissue. In liver, blood glucose concentrations are the main factor in control of the synthesis of glycogen; insulin has only a potentiating effect. In skeletal muscle and adipocytes, glucose alone has little effect on the activity of glycogen synthase, the limiting enzyme in glycogen synthesis.
Muscle cells lack the enzyme glucose 6-phosphatase, which is necessary to convert glucose 6-phosphate to free glucose. Therefore, glycogen breakdown in muscle provides glucose 6-phosphate for glycolysis within the muscle cell itself, not for release into the blood.
Skeletal muscles are unable to release glucose (because muscles lack glucose 6-phosphatase) and muscles glycogen is mainly a local energy substrate for exercise, rather than an energy source to maintain blood glucose concentration during fasting.
Skeletal muscle lacks glucose-6-phosphatase (G6Pase), an enzyme present in liver and kidney that hydrolyzes glucose-6-phosphate to free glucose for export into the bloodstream. In muscle, glycogenolysis produces glucose-6-phosphate, which enters glycolysis for local ATP production, confirming glycogen is stored for internal use only.
The breakdown of glycogen is facilitated by an enzyme which allows the release of glucose molecules that can be subsequently utilized for energy by the muscle. Glycogen acts as one of the key sources of glucose for the exercising muscle... During exercise, liver glycogen can also be broken down into glucose and released into the blood. The glucose in the blood can then be absorbed by the muscle to be used as energy in the same way as muscle glycogen.
Skeletal muscle doesn't have this enzyme so it simply uses the glucose 6-phosphate by sending it into the glycolysis pathway to make energy... bloodstream for other organs and tissues to use skeletal muscle doesn't have this enzyme.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
Expert review
How each expert evaluated the evidence and arguments
Expert 1 — The Logic Examiner
The logical chain from evidence to claim is robust and multiply corroborated: Sources 6 (Khan Academy), 7 (Frontiers), and 8 (LLM Background Knowledge) directly and explicitly state that skeletal muscle lacks glucose-6-phosphatase and therefore cannot release free glucose into the bloodstream, while Sources 2 and 4 establish that G6Pase expression is confined to liver, kidneys, and intestine — together these form a valid deductive chain (muscle lacks G6Pase → cannot hydrolyze G6P to free glucose → glycogen is used internally) that directly supports the claim. The opponent's objection that Source 2 uses "mainly" introduces a minor hedging concern, but this is overridden by the convergence of Sources 4, 6, and 7 which use unambiguous language about absence in muscle; the "exclusively glycolysis" quibble is a scope-narrowing distraction since the claim's core assertion — internal use rather than bloodstream release — is directly confirmed by Sources 3, 6, and 7, making the claim logically sound and well-supported with only trivial inferential gaps around edge-case metabolic pathways.
Expert 2 — The Context Analyst
The claim is broadly correct but omits nuance: glucose-6-phosphatase activity is characteristic of liver/kidney/intestine (and not skeletal muscle), yet sources like the G6Pase overview phrase this as “mainly” (Source 2) and the claim's “therefore” compresses multiple reasons muscle glycogen is retained/used locally (e.g., muscle's own ATP demand and lack of glucose export machinery), not solely a single-enzyme explanation (Sources 3, 6, 7). With full context, the core impression remains accurate—skeletal muscle glycogen is used locally because muscle lacks G6Pase and cannot dephosphorylate G6P to free glucose for blood release—though the causal framing is slightly oversimplified rather than wrong (Sources 6, 7; consistent with Sources 4 and 3).
Expert 3 — The Source Auditor
Higher-authority, largely independent biomedical sources explicitly support the key mechanistic point: Frontiers (Source 7) states skeletal muscle cannot release glucose because it lacks glucose-6-phosphatase, and Cleveland Clinic (Source 3) explains muscle glycogen is mainly local fuel that does not directly maintain blood glucose; PMC/NIH (Source 2) and Inserm HAL (Source 4) further align by placing physiologically relevant G6Pase expression in liver/kidney/intestine rather than muscle. The opponent's critique hinges on hedging words like “mainly” (Source 2) and on Source 1's different focus, but it does not provide any high-reliability counterevidence that skeletal muscle expresses functional G6Pase or exports glucose, so the claim is supported by the best available sources with only minor wording caveats (e.g., “for internal use” is broadly true even if muscle glycogen can feed non-export pathways besides glycolysis).
Expert summary
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
Multiple highly authoritative and independent sources converge on the same biochemical fact: skeletal muscle lacks glucose-6-phosphatase, the enzyme required to convert glucose-6-phosphate into free glucose for export — as confirmed explicitly by Source 6 (Khan Academy), Source 7 (Frontiers), and Source 8 (LLM Background Knowledge) — while Sources 2 (PMC - NIH) and 4 (Inserm HAL) further establish that glucose-6-phosphatase is expressed only in the liver, kidneys, and intestine, definitively excluding muscle. As a direct biochemical consequence, Source 6 and Source 7 both state that muscle glycogenolysis yields glucose-6-phosphate that is channeled exclusively into glycolysis for local ATP production, a conclusion reinforced by Source 3 (Cleveland Clinic), which confirms that muscle glycogen serves as an internal metabolic fuel without dramatically affecting blood glucose levels — precisely because muscle cannot release free glucose into the bloodstream.
You're treating secondary/explanatory sources as if they “confirm” a definitive tissue-wide absence, but your own higher-quality mechanistic sources don't actually say skeletal muscle lacks G6Pase—Source 2 (PMC - NIH) only says it's found “mainly” in liver and kidney, and Source 4 (Inserm HAL) is a liver-focused expression claim that doesn't directly demonstrate complete absence across all skeletal muscle contexts. And even if muscle can't export free glucose, you overreach by calling the fate of muscle glycogen “exclusively” glycolysis: Source 1 (PMC - Nutrition Reviews) and Source 3 (Cleveland Clinic) describe muscle glycogen as primarily local fuel and reducing blood glucose uptake, not a proof that glycogen is stored solely because of G6Pase absence or that none of it supports other intramuscular pathways.
Argument against
The motion overstates a tissue-wide absolute: the brief's strongest primary-style sources only say glucose-6-phosphatase is found “mainly” in liver and kidney (Source 2, PMC - NIH) or discuss expression patterns without directly proving complete absence in all skeletal muscle contexts (Source 4, Inserm HAL), so the claimed causal chain (“lacks G6Pase and therefore…”) is not actually demonstrated. Moreover, even the athlete-focused review emphasizes muscle glycogen's role in reducing blood glucose uptake during exercise rather than asserting an exclusive “internal use rather than releasing glucose” mechanism (Source 1, PMC - Nutrition Reviews), making the motion's definitive conclusion broader than what the cited evidence supports.
Your first objection commits a fallacy of false ambiguity: while Source 2 uses "mainly," Source 4 (Inserm HAL) explicitly states G6Pase "is expressed only in the liver, kidneys, and intestine," and Source 6 (Khan Academy) and Source 7 (Frontiers) directly and unambiguously state that muscle cells "lack" glucose-6-phosphatase and therefore "are unable to release glucose" — these are not hedged claims, and you cannot undermine a convergence of independent, highly authoritative sources by selectively quoting the least precise one. Your second objection is a red herring: Source 1's framing around exercise physiology does not contradict the mechanistic claim; it is Source 3 (Cleveland Clinic), Source 6, and Source 7 that explicitly confirm muscle glycogen is used internally "not for release into the blood," which is precisely what the motion asserts.